NASDAQ : PMVP
PMV Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.35 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 101.94M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 15.62M | 16.33M | 20.90M | 24.25M | 25.05M | 21.80M |
| Research & Development | 64.04M | 69.88M | 57.93M | 55.88M | 51.99M | 36.49M |
| Operating Expenses | 79.67M | 86.21M | 78.83M | 80.13M | 77.04M | 58.29M |
| Operating Income | -79.67M | -86.21M | -78.83M | -80.13M | -77.04M | -58.29M |
| Interest & Investment Income | 4.48M | 6.34M | 10.65M | 11.17M | 3.63M | 449.00K |
| Other Non Operating Income (Expenses) | -13.00K | -45.00K | -16.00K | 3.00K | 87.00K | 21.00K |
| EBT Excluding Unusual Items | -75.20M | -79.91M | -68.19M | -68.96M | -73.33M | -57.82M |
| Merger & Restructuring Charges | -597.00K | |||||
| Asset Writedown | -6.02M | |||||
| Pretax Income | -75.20M | -79.91M | -74.81M | -68.96M | -73.33M | -57.82M |
| Income Tax Expense | 22.00K | -2.17M | -16.10M | 2.00K | -9.00K | 23.00K |
| Net Income | -75.22M | -77.74M | -58.71M | -68.96M | -73.32M | -57.85M |
| Net Income to Common | -75.22M | -77.74M | -58.71M | -68.96M | -73.32M | -57.85M |
| Shares Outstanding (Basic) | 53.23M | 52.54M | 51.58M | 48.01M | 45.59M | 45.14M |
| Shares Outstanding (Diluted) | 53.23M | 52.54M | 51.58M | 48.01M | 45.59M | 45.14M |
| EPS (Basic) | -1.41 | -1.48 | -1.14 | -1.44 | -1.61 | -1.28 |
| EPS (Diluted) | -1.41 | -1.48 | -1.14 | -1.44 | -1.61 | -1.28 |
| Free Cash Flow | -71.28M | -73.61M | -51.94M | -56.62M | -71.74M | -47.92M |
| Free Cash Flow Per Share | -1.34 | -1.40 | -1.01 | -1.18 | -1.57 | -1.06 |
| EBITDA | -79.54M | -86.07M | -77.68M | -78.88M | -76.72M | -57.99M |
| D&A For EBITDA | 122.00K | 133.00K | 1.14M | 1.26M | 315.00K | 307.00K |
| EBIT | -79.67M | -86.21M | -78.83M | -80.13M | -77.04M | -58.29M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 12.47M | 37.98M | 40.88M | 37.71M | 108.30M | 172.47M |
| Short-Term Investments | 66.96M | 74.96M | 128.58M | 165.35M | 132.76M | 124.70M |
| Cash & Short-Term Investments | 79.43M | 112.94M | 169.45M | 203.06M | 241.05M | 297.16M |
| Prepaid Expenses | 1.98M | 2.28M | 6.20M | 3.53M | 5.13M | 3.30M |
| Restricted Cash | 822.00K | 822.00K | 822.00K | |||
| Total Current Assets | 81.41M | 115.23M | 175.66M | 207.41M | 247.01M | 301.29M |
| Property, Plant & Equipment | 363.00K | 1.04M | 1.55M | 19.05M | 20.49M | 13.15M |
| Long-Term Investments | 13.84M | 25.50M | 2.50M | 16.91M | ||
| Other Long-Term Assets | 296.00K | 297.00K | 235.00K | 190.00K | 313.00K | 221.00K |
| Total Assets | 82.07M | 116.56M | 191.29M | 252.15M | 270.31M | 331.57M |
| Accounts Payable | 2.02M | 3.15M | 6.58M | 3.24M | 3.00M | 3.19M |
| Accrued Expenses | 8.33M | 7.86M | 7.44M | 9.94M | 7.31M | 8.63M |
| Current Portion of Leases | 217.00K | 403.00K | 352.00K | 852.00K | 528.00K | 403.00K |
| Total Current Liabilities | 10.57M | 11.41M | 14.37M | 14.03M | 10.83M | 12.22M |
| Long-Term Leases | 435.00K | 838.00K | 12.43M | 13.45M | 10.79M | |
| Total Liabilities | 10.57M | 11.85M | 15.21M | 26.46M | 24.28M | 23.01M |
| Additional Paid-In Capital | 554.16M | 551.08M | 544.65M | 535.47M | 487.52M | 476.36M |
| Retained Earnings | -482.58M | -446.45M | -368.71M | -310.00M | -241.04M | -167.73M |
| Comprehensive Income & Other | -82.00K | 84.00K | 139.00K | 224.00K | -445.00K | -78.00K |
| Total Common Equity | 71.50M | 104.71M | 176.08M | 225.69M | 246.03M | 308.56M |
| Shareholders' Equity | 71.50M | 104.71M | 176.08M | 225.69M | 246.03M | 308.56M |
| Total Liabilities & Equity | 82.07M | 116.56M | 191.29M | 252.15M | 270.31M | 331.57M |
| Total Debt | 217.00K | 838.00K | 1.19M | 13.29M | 13.98M | 11.19M |
| Net Cash (Debt) | 79.21M | 112.11M | 182.11M | 215.28M | 229.57M | 302.88M |
| Net Cash Per Share | 1.49 | 2.13 | 3.53 | 4.48 | 5.04 | 6.71 |
| Filing Date Shares Outstanding | 53.46M | 53.33M | 51.93M | 51.44M | 45.77M | 45.45M |
| Total Common Shares Outstanding | 53.46M | 53.33M | 51.94M | 51.45M | 45.77M | 45.43M |
| Working Capital | 70.84M | 103.81M | 161.29M | 193.38M | 236.17M | 289.07M |
| Book Value Per Share | 1.34 | 1.96 | 3.39 | 4.39 | 5.38 | 6.79 |
| Tangible Book Value | 71.50M | 104.71M | 176.08M | 225.69M | 246.03M | 308.56M |
| Tangible Book Value Per Share | 1.34 | 1.96 | 3.39 | 4.39 | 5.38 | 6.79 |
| Machinery | 1.46M | 1.48M | 1.82M | 3.17M | 2.53M | 2.28M |
| Leasehold Improvements | 45.00K | 81.00K | 51.00K | 10.77M | 409.00K | 161.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -75.22M | -77.74M | -58.71M | -68.96M | -73.32M | -57.85M |
| Depreciation & Amortization | 122.00K | 133.00K | 1.14M | 1.26M | 315.00K | 307.00K |
| Loss (Gain) From Sale of Assets | 24.00K | 37.00K | 62.00K | |||
| Loss (Gain) From Sale of Investments | -1.97M | -2.77M | -5.37M | -5.39M | -628.00K | 550.00K |
| Stock-Based Compensation | 5.68M | 5.92M | 8.87M | 12.38M | 10.20M | 5.34M |
| Other Operating Activities | -80.00K | -72.00K | 4.31M | -370.00K | 243.00K | 955.00K |
| Change in Accounts Payable | -578.00K | -3.42M | 3.34M | 235.00K | -389.00K | 191.00K |
| Change in Other Net Operating Assets | 758.00K | 4.34M | -4.93M | 5.19M | -179.00K | 3.93M |
| Operating Cash Flow | -71.27M | -73.58M | -51.28M | -55.66M | -63.76M | -46.57M |
| Capital Expenditures | -14.00K | -29.00K | -655.00K | -962.00K | -7.98M | -1.35M |
| Sale of Property, Plant & Equipment | 1.00K | 31.00K | 251.00K | |||
| Investment in Securities | 39.08M | 70.17M | 53.76M | -49.58M | 6.62M | -142.24M |
| Investing Cash Flow | 39.07M | 70.17M | 53.35M | -50.55M | -1.37M | -143.58M |
| Issuance of Common Stock | 535.00K | 505.00K | 313.00K | 35.58M | 958.00K | 2.02M |
| Financing Cash Flow | 535.00K | 505.00K | 313.00K | 35.58M | 958.00K | 2.02M |
| Foreign Exchange Rate Adjustments | 3.00K | 7.00K | -35.00K | 34.00K | ||
| Net Cash Flow | -31.66M | -2.89M | 2.35M | -70.59M | -64.17M | -188.13M |
| Free Cash Flow | -71.28M | -73.61M | -51.94M | -56.62M | -71.74M | -47.92M |
| Free Cash Flow Per Share | -1.34 | -1.40 | -1.01 | -1.18 | -1.57 | -1.06 |
| Levered Free Cash Flow | -43.82M | -46.94M | -40.92M | -32.94M | -48.97M | -27.51M |
| Unlevered Free Cash Flow | -43.82M | -46.94M | -40.92M | -32.94M | -48.97M | -27.51M |
| Cash Income Tax Paid | 23.00K | |||||
| Change in Working Capital | 180.00K | 914.00K | -1.59M | 5.43M | -568.00K | 4.12M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 98.92M | 66.51M | 78.14M | 158.59M | 397.29M | 1.05B |
| Enterprise Value | 19.71M | -61.80M | -106.53M | -66.81M | 150.96M | 733.25M |
| Last Close Price | 1.31 | 1.25 | 1.51 | 3.10 | 8.70 | 23.10 |
| PB Ratio | 0.98 | 0.64 | 0.44 | 0.70 | 1.61 | 3.40 |
| P/TBV Ratio | 1.38 | 0.64 | 0.44 | 0.70 | 1.61 | 3.40 |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | 0.06 | 0.06 | 0.04 |
| Net Debt / Equity Ratio | -1.11 | -1.07 | -1.03 | -0.95 | -0.93 | -0.98 |
| Net Debt / EBITDA Ratio | 1.00 | 1.30 | 2.34 | 2.73 | 2.99 | 5.22 |
| Net Debt / FCF Ratio | 1.11 | 1.52 | 3.51 | 3.80 | 3.20 | 6.32 |
| Quick Ratio | 7.52 | 9.89 | 11.79 | 14.47 | 22.25 | 24.32 |
| Current Ratio | 7.70 | 10.09 | 12.22 | 14.78 | 22.80 | 24.66 |
| Return on Equity (ROE) | -70.93% | -55.37% | -29.23% | -29.24% | -26.44% | -17.33% |
| Return on Assets (ROA) | -42.39% | -35.00% | -22.22% | -19.17% | -16.00% | -10.45% |
| Return on Capital Employed (ROCE) | -111.40% | -82.00% | -44.60% | -33.70% | -29.70% | -18.30% |
| Earnings Yield | -107.87% | -116.88% | -75.13% | -43.48% | -18.45% | -5.52% |
| FCF Yield | -72.06% | -110.66% | -66.47% | -35.70% | -18.06% | -4.57% |
| Buyback Yield / Dilution | -2.69% | -1.87% | -7.42% | -5.31% | -1.01% | -214.23% |